Skip to main content

Table 2 Patient characteristics, as categorized by treatment duration and discontinuation, all genotypes

From: High rates of early treatment discontinuation in hepatitis C-infected US veterans

 

Total (N = 20,499)

Discontinued for non-LOE reasons (N = 4637)

Discontinued due to LOE (N = 1408)

Unknown (N = 5202)

Completed ≥20/44 wks of therapy (N = 9252)

N

%

CI-LL

CI-UL

N

%

CI-LL

CI-UL

N

%

CI-LL

CI-UL

N

%

CI-LL

CI-UL

N

%

CI-LL

CI-UL

DEMOGRAPHIC VARIABLES

                   

Age

                    

< 50

4636

22.6%

22.1%

23.1%

964

20.8%

19.8%

21.8%

288

20.5%

18.7%

22.2%

1074

20.6%

19.7%

21.6%

2310

25.0%

24.2%

25.7%

50-64

15388

75.1%

74.6%

75.6%

3557

76.7%

75.7%

77.7%

1085

77.1%

75.2%

78.9%

3983

76.6%

75.6%

77.5%

6763

73.1%

72.3%

73.9%

65+

475

2.3%

2.1%

2.5%

116

2.5%

2.1%

2.9%

35

2.5%

1.8%

3.2%

145

2.8%

2.4%

3.2%

179

1.9%

1.7%

2.2%

BMI

                    

< 18.5

88

0.4%

0.4%

0.5%

34

0.7%

0.5%

0.9%

6

0.4%

0.1%

0.7%

16

0.3%

0.2%

0.4%

32

0.3%

0.2%

0.4%

18.5 – 24.9

4910

24.0%

23.5%

24.4%

1179

25.4%

24.4%

26.5%

316

22.4%

20.6%

24.3%

1234

23.7%

22.8%

24.7%

2181

23.6%

22.8%

24.3%

25 – 29.9

8583

41.9%

41.3%

42.4%

1941

41.9%

40.7%

43.1%

620

44.0%

41.9%

46.2%

2162

41.6%

40.4%

42.7%

3860

41.7%

40.9%

42.6%

30+

6708

32.7%

32.2%

33.3%

1423

30.7%

29.6%

31.8%

456

32.4%

30.3%

34.4%

1736

33.4%

32.3%

34.4%

3093

33.4%

32.6%

34.2%

Unknown

210

1.0%

0.9%

1.1%

60

1.3%

1.0%

1.6%

10

0.7%

0.3%

1.1%

54

1.0%

0.8%

1.3%

86

0.9%

0.8%

1.1%

Marital status

                    

Married

6985

34.1%

33.5%

34.6%

1459

31.5%

30.3%

32.6%

501

35.6%

33.5%

37.7%

1784

34.3%

33.2%

35.4%

3241

35.0%

34.2%

35.8%

Not married

3480

17.0%

16.5%

17.4%

798

17.2%

16.3%

18.1%

259

18.4%

16.7%

20.1%

821

15.8%

15.0%

16.6%

1602

17.3%

16.7%

18.0%

Other/unknown

10034

48.9%

48.4%

49.5%

2380

51.3%

50.1%

52.5%

648

46.0%

43.8%

48.2%

2597

49.9%

48.8%

51.1%

4409

47.7%

46.8%

48.5%

Race

                    

White

5375

26.2%

25.7%

26.7%

1184

25.5%

24.5%

26.6%

313

22.2%

20.4%

24.1%

1243

23.9%

22.9%

24.9%

2635

28.5%

27.7%

29.3%

Black

2738

13.4%

13.0%

13.7%

741

16.0%

15.1%

16.9%

274

19.5%

17.7%

21.2%

873

16.8%

15.9%

17.6%

850

9.2%

8.7%

9.7%

Hispanic

679

3.3%

3.1%

3.5%

149

3.2%

2.8%

3.6%

48

3.4%

2.6%

4.2%

162

3.1%

2.7%

3.5%

320

3.5%

3.1%

3.8%

Other/unknown

11706

57.1%

56.5%

57.7%

2563

55.3%

54.1%

56.5%

773

54.9%

52.7%

57.1%

2923

56.2%

55.1%

57.3%

5447

58.9%

58.0%

59.7%

Sex (male)

19708

96.1%

95.9%

96.4%

4484

96.7%

96.3%

97.1%

1359

96.5%

95.7%

97.3%

5011

96.3%

95.9%

96.8%

8854

95.7%

95.4%

96.0%

LABORATORY VARIABLES

                   

Genotype

                    

G1/4

14,893

100%

NA

NA

3562

23.9%

NA

NA

1405

9.4%

NA

NA

4560

30.6%

NA

NA

5366

36.0%

NA

NA

G2/3

5606

100%

NA

NA

1075

19.2%

NA

NA

3

0.1%

NA

NA

642

11.5%

NA

NA

3886

69.3%

NA

NA

Albumin

                    

< 3.5 mg/dL

1139

5.6%

5.3%

5.8%

312

6.7%

6.1%

7.3%

90

6.4%

5.3%

7.5%

354

6.8%

6.2%

7.4%

383

4.1%

3.8%

4.5%

3.5+ mg/dL (normal)

17966

87.6%

87.3%

88.0%

3973

85.7%

84.8%

86.5%

1249

88.7%

87.3%

90.1%

4486

86.2%

85.5%

87.0%

8258

89.3%

88.7%

89.8%

Missing

1394

6.8%

6.5%

7.1%

352

7.6%

7.0%

8.2%

69

4.9%

4.0%

5.8%

362

7.0%

6.4%

7.5%

611

6.6%

6.2%

7.0%

ALT

                    

< 30 IU/mL (normal)

1264

6.2%

5.9%

6.4%

292

6.3%

5.7%

6.9%

65

4.6%

3.7%

5.5%

306

5.9%

5.3%

6.4%

601

6.5%

6.1%

6.9%

30-90 IU/mL (elevated 1x-3x ULN)

10115

49.3%

48.8%

49.9%

2306

49.7%

48.5%

50.9%

750

53.3%

51.1%

55.5%

2670

51.3%

50.2%

52.5%

4389

47.4%

46.6%

48.3%

90+ IU/mL (3+ x ULN)

7788

38.0%

37.4%

38.5%

1726

37.2%

36.1%

38.4%

530

37.6%

35.5%

39.8%

1857

35.7%

34.6%

36.8%

3675

39.7%

38.9%

40.6%

Missing

1332

6.5%

6.2%

6.8%

313

6.8%

6.1%

7.4%

63

4.5%

3.6%

5.4%

369

7.1%

6.5%

7.7%

587

6.3%

5.9%

6.8%

Bilirubin

                    

< 1.5 mg/dL (normal)

17327

84.5%

84.1%

84.9%

3846

82.9%

82.0%

83.9%

1220

86.6%

85.2%

88.1%

4332

83.3%

82.4%

84.1%

7929

85.7%

85.1%

86.3%

1.5 + mg/dL

1472

7.2%

6.9%

7.5%

387

8.3%

7.7%

9.0%

106

7.5%

6.4%

8.7%

402

7.7%

7.1%

8.3%

577

6.2%

5.8%

6.7%

Missing

1700

8.3%

8.0%

8.6%

404

8.7%

8.0%

9.4%

82

5.8%

4.8%

6.9%

468

9.0%

8.3%

9.6%

746

8.1%

7.6%

8.5%

Creatinine

                    

< 1.1 mg/dL (normal)

2474

12.1%

11.7%

12.4%

537

11.6%

10.8%

12.4%

219

15.6%

14.0%

17.1%

611

11.7%

11.0%

12.5%

1107

12.0%

11.4%

12.5%

1.1 + mg/dL

2062

10.1%

9.7%

10.4%

505

10.9%

10.1%

11.6%

147

10.4%

9.1%

11.8%

529

10.2%

9.5%

10.9%

881

9.5%

9.0%

10.0%

Missing

15963

77.9%

77.4%

78.3%

3595

77.5%

76.5%

78.5%

1042

74.0%

72.1%

75.9%

4062

78.1%

77.1%

79.0%

7264

78.5%

77.8%

79.2%

Hemoglobin

                    

Anemiac

754

3.7%

3.5%

3.9%

196

4.2%

3.7%

4.7%

46

3.3%

2.5%

4.0%

242

4.7%

4.2%

5.1%

270

2.9%

2.6%

3.2%

13+ g/dL m.; 12+ g/dL f. (normal)

18425

89.9%

89.5%

90.2%

4090

88.2%

87.4%

89.0%

1288

91.5%

90.3%

92.7%

4617

88.8%

88.0%

89.5%

8430

91.1%

90.6%

91.6%

Missing

1320

6.4%

6.2%

6.7%

351

7.6%

6.9%

8.2%

74

5.3%

4.3%

6.2%

343

6.6%

6.0%

7.2%

552

6.0%

5.6%

6.4%

LDL

                    

< 100 mg/dL (normal)

6745

32.9%

32.4%

33.4%

1574

33.9%

32.8%

35.1%

537

38.1%

36.0%

40.3%

1847

35.5%

34.4%

36.6%

2787

30.1%

29.3%

30.9%

100 + mg/dL

9811

47.9%

47.3%

48.4%

2195

47.3%

46.1%

48.5%

636

45.2%

43.0%

47.4%

2332

44.8%

43.7%

46.0%

4648

50.2%

49.4%

51.1%

Missing

3943

19.2%

18.8%

19.7%

868

18.7%

17.8%

19.7%

235

16.7%

15.1%

18.3%

1023

19.7%

18.8%

20.6%

1817

19.6%

19.0%

20.3%

Platelet

                    

< 100/mm3

865

4.2%

4.0%

4.5%

255

5.5%

4.9%

6.1%

69

4.9%

4.0%

5.8%

236

4.5%

4.1%

5.0%

305

3.3%

3.0%

3.6%

100 +/mm3 (normal)

18202

88.8%

88.4%

89.2%

4023

86.8%

85.9%

87.6%

1259

89.4%

88.1%

90.8%

4583

88.1%

87.4%

88.8%

8337

90.1%

89.6%

90.6%

Missing

1432

7.0%

6.7%

7.3%

359

7.7%

7.1%

8.4%

80

5.7%

4.7%

6.7%

383

7.4%

6.8%

8.0%

610

6.6%

6.2%

7.0%

  1. cAnemia defined as hemoglobin <12 g/dL if female or <13 g/dL if male.
  2. Key: CI – 95% confidence interval; LL – lower limit; UL – upper limit; NA – Not applicable; D/C – discontinuation; LOE – lack of efficacy; (ref) – reference value; BMI - body mass index; VISN – Veterans Integrated Service Network; COPD - chronic obstructive pulmonary disease; HIV - human immunodeficiency virus; ALT - alanine aminotransferase; ULN – upper limit of normal; LDL - low density lipoprotein.